These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37889402)

  • 1. Local delivery of doxorubicin prodrug via lipid nanocapsule-based hydrogel for the treatment of glioblastoma.
    Wang M; Bergès R; Malfanti A; Préat V; Bastiancich C
    Drug Deliv Transl Res; 2024 Dec; 14(12):3322-3338. PubMed ID: 37889402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
    Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
    Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
    Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
    Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells.
    Bozzato E; Tsakiris N; Paquot A; Muccioli GG; Bastiancich C; Préat V
    Int J Pharm; 2022 Nov; 628():122341. PubMed ID: 36341916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment.
    Bastiancich C; Bozzato E; Luyten U; Danhier F; Bastiat G; Préat V
    Int J Pharm; 2019 Mar; 559():220-227. PubMed ID: 30703501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
    Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
    Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models.
    Bastiancich C; Lemaire L; Bianco J; Franconi F; Danhier F; Préat V; Bastiat G; Lagarce F
    Nanomedicine (Lond); 2018 Aug; 13(16):1999-2013. PubMed ID: 30204064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastoma.
    Wang M; Malfanti A; Bastiancich C; Préat V
    Int J Pharm X; 2023 Dec; 5():100147. PubMed ID: 36620521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
    Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
    Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-free hydrogel made of lipid nanocapsules, as a local drug delivery platform.
    Pitorre M; Gazaille C; Pham LTT; Frankova K; Béjaud J; Lautram N; Riou J; Perrot R; Geneviève F; Moal V; Benoit JP; Bastiat G
    Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112188. PubMed ID: 34082987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
    Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
    Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-loaded liposome-like particles embedded in chitosan/hyaluronic acid-based hydrogels as a controlled drug release model for local treatment of glioblastoma.
    Adiguzel S; Karamese M; Kugu S; Kacar EA; Esen MF; Erdogan H; Tasoglu S; Bacanli MG; Altuntas S
    Int J Biol Macromol; 2024 Oct; 278(Pt 4):135054. PubMed ID: 39187114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
    Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
    Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
    J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of aldoxorubicin in an intracranial xenograft mouse model of human glioblastoma.
    Marrero L; Wyczechowska D; Musto AE; Wilk A; Vashistha H; Zapata A; Walker C; Velasco-Gonzalez C; Parsons C; Wieland S; Levitt D; Reiss K; Prakash O
    Neoplasia; 2014 Oct; 16(10):874-82. PubMed ID: 25379024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.